NovaBridge Biosciences

NBP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$68,263$2,141,445$3,214,005$3,523,632
Short-Term Investments$105,135$20,221$235,429$753,164
Receivables$1,172$1,833$4,812$60,952
Inventory$0$28,955-$80,278$4,273
Other Curr. Assets$2,123$16,352$252,508$4,045,528
Total Curr. Assets$176,693$2,336,669$3,626,476$4,781,718
Property Plant & Equip (Net)$3,798$5,554$123,966$158,497
Goodwill$0$0$162,574$162,574
Intangibles$0$16,662$118,888$119,666
Long-Term Investments$30,824$1,688$30,850$380,342
Tax Assets$0$0$0$0
Other NC Assets$1,365$252,394$10,911$26,634
Total NC Assets$35,987$276,298$447,189$847,713
Other Assets$0$0$0$0
Total Assets$212,680$2,612,967$4,073,665$5,629,431
Liabilities
Payables$0$0$0$0
Short-Term Debt$816$51,860$6,220$30,669
Tax Payable$0$0$0$0
Deferred Revenue$106$1,582$2,189$2,369
Other Curr. Liab.$7,532$358,372$651,332$590,966
Total Curr. Liab.$8,454$411,814$659,742$624,004
LT Debt$3,066$82,012$32,069$194,241
Deferred Rev, NC$0$0$0$224,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1$400,985$373,528-$610
Total NC Liab.$3,066$482,997$405,597$417,631
Other Liabilities$0$0$0$0
Cap. Leases$3,882$44,989$35,542$112,455
Total Liabilities$11,520$894,811$1,065,339$1,041,635
Equity
Pref Stock$0$2,309$0$28,236
Common Stock$19$19$132$126
Retained Earnings-$1,286,039-$8,327,844-$6,766,655-$4,354,833
AOCI$33,384$39,771$216,723-$186,510
Other Equity$1,453,796$10,006,210$9,558,126$9,100,777
Total Equity$201,160$1,718,156$3,008,326$4,587,796
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$212,680$2,612,967$4,073,665$5,629,431
Net Debt-$64,381-$2,007,573-$3,175,716-$3,298,722
NovaBridge Biosciences (NBP) Financial Statements & Key Stats | AlphaPilot